Future Medicine Co., Ltd. (XKON:341170)
South Korea
· Delayed Price · Currency is KRW 1,598.00
-85.00 (-5.05%)
At close: Mar 9, 2026
Future Medicine Market Cap
Future Medicine has a market cap or net worth of 14.82 billion as of March 9, 2026. Its market cap has increased by 24.26% in one year.
Market Cap
14.82B
Enterprise Value
n/a
Revenue
1.00B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,598.00
Market Cap Chart
Since July 27, 2022, Future Medicine's market cap has decreased from 89.97B to 14.82B, a decrease of -83.53%. That is a compound annual growth rate of -39.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 14.82B | -48.45% |
| Dec 30, 2025 | 28.75B | 144.48% |
| Dec 30, 2024 | 11.76B | -81.54% |
| Dec 28, 2023 | 63.72B | 34.97% |
| Dec 29, 2022 | 47.21B | -47.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioten | 13.54B |
| Kwangdong Healthbio | 18.02B |
| CXI Healthcare Technology Group | 12.38B |
| Union Korea Pharm | 19.70B |
| WooGene B&G | 20.63B |
| BIFIDO | 23.27B |
| Daesung Microbiological Labs. | 24.09B |
| ChoA Pharmaceutical Co., LTD. | 26.98B |